News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

New nanoparticle technology offers hope for hard-to-treat diseases [Yahoo! Finance]

Here's Why We're Not Too Worried About Arvinas' (NASDAQ:ARVN) Cash Burn Situation [Yahoo! Finance]

Arvinas (NASDAQ:ARVN) was upgraded by analysts at Citigroup Inc. from a "neutral" rating to a "buy" rating.

Arvinas (NASDAQ:ARVN) was given a new $18.00 price target on by analysts at Barclays PLC. They now have an "overweight" rating on the stock.

How the Narrative Surrounding Pfizer Is Changing After Obesity Deals and Sector Rerating [Yahoo! Finance]

11/5/2025

07:00 am

arvn

0.3%

BEAT

8/6/2025

07:00 am

arvn

-16.5%

BEAT

5/1/2025

07:00 am

arvn

-1.1%

BEAT

2/11/2025

07:00 am

arvn

-6.8%

BEAT

Form 8-K ARVINAS, INC. For: Dec 06

Form SCHEDULE 13G ARVINAS, INC. Filed by: D. E. SHAW & CO, L.P.

Form SCHEDULE 13G/A ARVINAS, INC. Filed by: CITADEL ADVISORS LLC

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}